Erlotiniblet and suicidal ideation Patient Reports February 09, 2012

Erlotiniblet Side Effects Report #5311632-0
Erlotiniblet side effect was reported by a Health Professional from UNITED STATES on Apr 26, 2007. Female patient, 49 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotiniblet. After drug was administered, patient experienced the following side effects: suicidal ideation. Erlotiniblet dosage: 150 MG, QD, ORAL. During the same period patient was treated with FULVESTRANT, LEXAPRO, OXYCODONE, ONDANSETRON, PROCHLORPERAZINE. Patient recovered.